Skip to content

AX Workstation DR-Viewer Software Option

by Siemens Corp.

510(k) K992925

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK992925 Date23 Nov 1999ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LLZ
Device Class
Class II
Regulation
21 CFR Part 892.2050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The AX Workstation DR-Viewer Software Option is an accessory to the AX Workstation that processes radiographic, fluoroscopic, or angiographic x-ray images of the spine, legs, or colon. It reconstructs multiple input images into a single composite image format for viewing and analysis.

Physicians use the workstation to view these composites and apply measurement and post-processing tools. The software option is loaded and executed on the AX Workstation and is supplied as part of the system. It received FDA 510(k) clearance under K992925 and is classified under product code LLZ in the Radiology advisory committee review.

Other devices from Siemens Corp.

See all devices from Siemens Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of medical images can the AX Workstation DR-Viewer Software Option process and analyze?

    The AX Workstation DR-Viewer Software Option is designed to process radiographic, fluoroscopic, and angiographic X-ray images specifically of the spine, legs, or colon. It reconstructs multiple input images into a single composite format, allowing physicians to view and analyze these combined images for diagnostic purposes.

  • How is the AX Workstation DR-Viewer Software Option supplied and integrated into the system?

    The software option is supplied as part of the AX Workstation system and is loaded directly onto it. It is not a standalone device but an accessory that enhances the workstation’s capabilities by enabling image reconstruction and analysis tools for radiographic, fluoroscopic, or angiographic studies.

  • What kind of measurement and analysis tools does the software provide for physicians?

    The AX Workstation DR-Viewer Software Option includes post-processing tools that allow physicians to apply measurements and further analyze the reconstructed composite images. These tools help in evaluating the combined radiographic, fluoroscopic, or angiographic data for improved diagnostic accuracy.

  • Is the AX Workstation DR-Viewer Software Option intended for single-use or repeated use in clinical settings?

    The AX Workstation DR-Viewer Software Option is not a consumable device like a single-use item. Since it is a software option loaded onto the AX Workstation, it is designed for repeated use in clinical settings, enabling continuous processing and analysis of X-ray images over time.

  • What was the regulatory pathway and classification for the FDA clearance of this software option?

    The AX Workstation DR-Viewer Software Option received FDA clearance through a traditional 510(k) review process under the product code LLZ, classified under the Radiology advisory committee (RA). The clearance was granted as substantially equivalent to a predicate device, with the submission filed in 1999 and decided on November 23, 1999.